Home > Boards > US Listed > Biotechs > Vascular Biogenics Ltd. (VBLT)

Anyone care to speculate on what happens next

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
MF82 Member Profile
 
Followed By 5
Posts 299
Boards Moderated 0
Alias Born 06/01/14
160x600 placeholder
VBL Therapeutics Presents MOSPD2 Bi-Specific Antibody Activity and Potential Survival Benefit for Solid Tumors in Late Breaki... GlobeNewswire Inc. - 6/22/2020 8:00:10 AM
VBL Presents New Data on the Potential of its Novel anti-MOSPD2 Monoclonal Antibodies for Rheumatoid Arthritis at the EULAR 2... GlobeNewswire Inc. - 6/4/2020 7:00:10 AM
VBL Therapeutics to Present New Data on Its MOSPD2 Bispecific Antibody Program for Solid Tumors in Late Breaking Research Ses... GlobeNewswire Inc. - 5/18/2020 7:00:10 AM
VBL Therapeutics Announces First Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/14/2020 7:00:10 AM
VBL Presents New Data on MOSPD2 Antibodies as Potential Treatment for NASH and Colitis at DDW GlobeNewswire Inc. - 5/6/2020 7:00:10 AM
VBL First-in-class MOSPD2 Antibodies Show Potential for Treatment for CNS Inflammation GlobeNewswire Inc. - 5/4/2020 7:00:10 AM
VBL Therapeutics to Report Fourth Quarter 2019 Financial Results on March 19 GlobeNewswire Inc. - 3/2/2020 8:00:10 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/21/2020 2:52:42 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/30/2019 4:16:02 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/23/2019 4:16:33 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/14/2019 7:01:47 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/1/2019 4:16:15 PM
VBL Therapeutics to Report Third Quarter 2019 Financial Results on November 14 GlobeNewswire Inc. - 10/31/2019 8:00:05 AM
Amended Report of Foreign Issuer (6-k/a) Edgar (US Regulatory) - 8/29/2019 5:26:17 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/13/2019 7:01:03 AM
VBL Therapeutics to Report Second Quarter 2019 Financial Results on August 13 GlobeNewswire Inc. - 8/5/2019 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 8/1/2019 11:17:55 AM
VBL Therapeutics Announces Modiin Production Facility Received a GMP Compliance Certificate Following EU QP Audit GlobeNewswire Inc. - 7/22/2019 8:00:00 AM
MF82   Monday, 09/17/18 08:26:48 PM
Re: None
Post # of 2003 
Anyone care to speculate on what happens next with rgbm and vb111?
Would they re-do phase 3? Attempt to get it approved with the full analysis?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2020 InvestorsHub.com, Inc.